According to Amarin Corporation 's latest financial reports the company's current revenue (TTM) is $0.30 B. In 2022 the company made a revenue of $0.36 B a decrease over the years 2021 revenue that were of $0.58 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.30 B | -16.87% |
2022 | $0.36 B | -36.69% |
2021 | $0.58 B | -5.03% |
2020 | $0.61 B | 42.89% |
2019 | $0.42 B | 87.49% |
2018 | $0.22 B | 26.57% |
2017 | $0.18 B | 39.22% |
2016 | $0.13 B | 59.11% |
2015 | $81.75 M | 50.84% |
2014 | $54.2 M | 105.7% |
2013 | $26.35 M | |
2012 | N/A | |
2011 | N/A | |
2010 | N/A | |
2003 | -$15.03 M | -122.94% |
2002 | $65.5 M | 21.82% |
2001 | $53.77 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
AbbVie ABBV | $54.31 B | 17,598.29% | ๐บ๐ธ USA |
AstraZeneca AZN | $47.61 B | 15,412.97% | ๐ฌ๐ง UK |
GlaxoSmithKline GSK | $37.84 B | 12,232.25% | ๐ฌ๐ง UK |
Alkermes ALKS | $1.66 B | 441.98% | ๐ฎ๐ช Ireland |
Teva Pharmaceutical Industries TEVA | $15.84 B | 5,063.06% | ๐ฎ๐ฑ Israel |